{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T02:04:28Z","timestamp":1777860268680,"version":"3.51.4"},"reference-count":34,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JRS"],"published-print":{"date-parts":[[2020,8,12]]},"DOI":"10.3233\/jrs-200024","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T11:14:07Z","timestamp":1590750847000},"page":"111-116","source":"Crossref","is-referenced-by-count":29,"title":["Risk of using hydroxychloroquine as a treatment of COVID-19"],"prefix":"10.1177","volume":"31","author":[{"given":"Lo\u2019ai","family":"Alanagreh","sequence":"first","affiliation":[{"name":", , Hashemite University, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foad","family":"Alzoughool","sequence":"additional","affiliation":[{"name":", , Hashemite University, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manar","family":"Atoum","sequence":"additional","affiliation":[{"name":", , Hashemite University, Jordan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JRS-200024_ref1","volume-title":"Naming the Coronavirus Disease (COVID-19) and the Virus that causes it","author":"World Health Organization","year":"2020"},{"issue":"1","key":"10.3233\/JRS-200024_ref2","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak \u2013 an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"key":"10.3233\/JRS-200024_ref3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0065-3527(06)66005-3","article-title":"The molecular biology of coronaviruses","volume":"66","author":"Masters","year":"2006","journal-title":"Adv Virus Res"},{"key":"10.3233\/JRS-200024_ref4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"10.3233\/JRS-200024_ref5","doi-asserted-by":"crossref","first-page":"E331","DOI":"10.3390\/pathogens9050331","article-title":"The human coronavirus disease COVID-19: Its origin, characteristics, and insights into potential drugs and its mechanisms","volume":"29","author":"Alanagreh","year":"2020","journal-title":"Pathogens"},{"issue":"17","key":"10.3233\/JRS-200024_ref8","doi-asserted-by":"crossref","first-page":"9029","DOI":"10.1128\/JVI.01331-15","article-title":"The nucleocapsid protein of coronaviruses acts as a viral suppressor of RNA silencing in mammalian cells","volume":"89","author":"Cui","year":"2015","journal-title":"J Virol"},{"issue":"4","key":"10.3233\/JRS-200024_ref9","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","author":"Gorbalenya","year":"2020","journal-title":"Nat Microbiol"},{"issue":"5","key":"10.3233\/JRS-200024_ref10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jmv.25707","article-title":"Potential interventions for novel coronavirus in China: A systematic review","volume":"92","author":"Zhang","year":"2020","journal-title":"J Med Virol"},{"issue":"16","key":"10.3233\/JRS-200024_ref11","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.2020.4940","article-title":"Convalescent plasma to treat COVID-19","volume":"323","author":"Roback","year":"2020","journal-title":"JAMA"},{"issue":"2","key":"10.3233\/JRS-200024_ref12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3233\/JRS-201017","article-title":"Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19","volume":"31","author":"Alzoughool","year":"2020","journal-title":"Int J Risk Saf Med"},{"issue":"1","key":"10.3233\/JRS-200024_ref13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5582\/ddt.2020.01012","article-title":"Discovering drugs to treat coronavirus disease 2019 (COVID-19)","volume":"14","author":"Dong","year":"2020","journal-title":"Drug Discov Ther"},{"issue":"4","key":"10.3233\/JRS-200024_ref14","doi-asserted-by":"crossref","first-page":"105932","DOI":"10.1016\/j.ijantimicag.2020.105932","article-title":"Chloroquine and hydroxychloroquine as available weapons to fight COVID-19","volume":"55","author":"Colson","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"10.3233\/JRS-200024_ref15","doi-asserted-by":"crossref","first-page":"e00399-20","DOI":"10.1128\/AAC.00399-20","article-title":"Compounds with therapeutic potential against novel respiratory 2019 coronavirus","volume":"64","author":"Martinez","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.3233\/JRS-200024_ref16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Research"},{"key":"10.3233\/JRS-200024_ref17","doi-asserted-by":"crossref","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery. 2020;6(16).","DOI":"10.1038\/s41421-020-0156-0"},{"key":"10.3233\/JRS-200024_ref18","doi-asserted-by":"crossref","first-page":"105949","DOI":"10.1016\/j.ijantimicag.2020.105949","article-title":"Hydroxychloroquine and azithromycin as a treatment of COVID-19: Results of an open-label non-randomized clinical trial (pre-press)","author":"Gautret","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.3233\/JRS-200024_ref19","doi-asserted-by":"crossref","unstructured":"Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (pre-press). Clin Infect Dis. 2020;ciaa237.","DOI":"10.1093\/cid\/ciaa237"},{"issue":"3","key":"10.3233\/JRS-200024_ref20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41584-020-0372-x","article-title":"Mechanisms of action of hydroxychloroquine and chloroquine: Implications for rheumatology","volume":"16","author":"Schrezenmeier","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.3233\/JRS-200024_ref21","first-page":"1","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"},{"key":"10.3233\/JRS-200024_ref22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/s41564-020-0688-y","article-title":"Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses","volume":"5","author":"Letko","year":"2020","journal-title":"Nat Microbiol"},{"issue":"6965","key":"10.3233\/JRS-200024_ref23","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"issue":"6","key":"10.3233\/JRS-200024_ref24","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1128\/JVI.02582-15","article-title":"Isolation and characterization of a novel bat coronavirus closely related to the direct progenitor of severe acute respiratory syndrome coronavirus","volume":"90","author":"Yang","year":"2016","journal-title":"J Virol"},{"issue":"1","key":"10.3233\/JRS-200024_ref26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5582\/bst.2020.01047","article-title":"Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies","volume":"14","author":"Gao","year":"2020","journal-title":"Biosci Trends"},{"key":"10.3233\/JRS-200024_ref28","doi-asserted-by":"crossref","unstructured":"Zhou D, Dai S-M, Tong Q. COVID-19: A recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. J Antimicrob Chemother. 2020.","DOI":"10.1093\/jac\/dkaa114"},{"issue":"5","key":"10.3233\/JRS-200024_ref30","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/rheumatology\/kel402","article-title":"Heart conduction disorders related to antimalarials toxicity: An analysis of electrocardiograms in 85 patients treated with hydroxychloroquine for connective tissue diseases","volume":"46","author":"Costedoat-Chalumeau","year":"2007","journal-title":"Rheumatology"},{"issue":"12","key":"10.3233\/JRS-200024_ref31","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.cjca.2014.08.016","article-title":"Hydroxychloroquine-induced cardiomyopathy: Case report, pathophysiology, diagnosis, and treatment","volume":"30","author":"Yogasundaram","year":"2014","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.3233\/JRS-200024_ref32","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: A systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"issue":"6","key":"10.3233\/JRS-200024_ref33","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/eye.2016.298","article-title":"Hydroxychloroquine retinopathy","volume":"31","author":"Yusuf","year":"2017","journal-title":"Eye (Lond)"},{"issue":"6","key":"10.3233\/JRS-200024_ref34","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.ophtha.2016.01.058","article-title":"Recommendations on screening for chloroquine and hydroxychloroquine retinopathy (2016 revision)","volume":"123","author":"Marmor","year":"2016","journal-title":"Ophthalmology"},{"issue":"12","key":"10.3233\/JRS-200024_ref35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41584-018-0111-8","article-title":"Hydroxychloroquine retinopathy \u2014 implications of research advances for rheumatology care","volume":"14","author":"Jorge","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.3233\/JRS-200024_ref36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/jama.298.2.187","article-title":"Hydroxychloroquine and risk of diabetes in patients with rheumatoid arthritis","volume":"298","author":"Wasko","year":"2007","journal-title":"JAMA"},{"issue":"2","key":"10.3233\/JRS-200024_ref37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: From malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"10.3233\/JRS-200024_ref38","first-page":"e17","article-title":"Liver and kidney injuries in COVID-19 and their effects on drug therapy; A letter to editor","volume":"8","author":"Rismanbaf","year":"2020","journal-title":"Arch Acad Emerg Med"},{"issue":"4","key":"10.3233\/JRS-200024_ref39","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["International Journal of Risk & Safety in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JRS-200024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:45:14Z","timestamp":1777509914000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JRS-200024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,12]]},"references-count":34,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jrs-200024","relation":{},"ISSN":["0924-6479","1878-6847"],"issn-type":[{"value":"0924-6479","type":"print"},{"value":"1878-6847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,12]]}}}